Search research articles
Contact Us
Filters
Showing results (161-170 of 184) with videos related to
Page
of 19
Sort By:
International Journal of Radiation Biology
|
December 7, 2007
alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation
Sangita C Pawar, Shona Dougherty, Michael E Pennington, et al.
Journal of the National Cancer Institute
|
December 4, 1991
Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial
D S Alberts, N Mason-Liddil, P M Plezia, et al.
Cancer Research
|
November 15, 1988
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage
W T Bellamy, W S Dalton, J M Kailey, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Comparison of young clinical investigators' accuracy and reproducibility when measuring pulmonary and skin surface nodules using a circumferential measurement versus a standard caliper measurement: American Association for Cancer Research/American Society of Clinical Oncology Clinical Trials Workshop
W L Monsky, D K Heddens, G M Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2007
Therapeutic effect of anthracene-based anticancer agent ethonafide in an animal model of multiple sclerosis
Wen-Hua Piao, Rudy Wong, Xue-Feng Bai, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells
Katerina Dvorakova, Claire M Payne, Margaret E Tome, et al.
Journal of the National Cancer Institute
|
April 6, 1994
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial
F L Meyskens, E Surwit, T E Moon, et al.
Cancer Biology & Therapy
|
December 9, 2014
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
Betty K Samulitis, Kelvin W Pond, Erika Pond, et al.
Experimental and Therapeutic Medicine
|
April 25, 2012
Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance
Margaret E Tome, Jennifer B Frye, Donna L Coyle, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 184) with videos related to
Sort By:
Page
of 19
International Journal of Radiation Biology
|
December 7, 2007
alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation
Sangita C Pawar, Shona Dougherty, Michael E Pennington, et al.
Journal of the National Cancer Institute
|
December 4, 1991
Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial
D S Alberts, N Mason-Liddil, P M Plezia, et al.
Cancer Research
|
November 15, 1988
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage
W T Bellamy, W S Dalton, J M Kailey, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Comparison of young clinical investigators' accuracy and reproducibility when measuring pulmonary and skin surface nodules using a circumferential measurement versus a standard caliper measurement: American Association for Cancer Research/American Society of Clinical Oncology Clinical Trials Workshop
W L Monsky, D K Heddens, G M Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2007
Therapeutic effect of anthracene-based anticancer agent ethonafide in an animal model of multiple sclerosis
Wen-Hua Piao, Rudy Wong, Xue-Feng Bai, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells
Katerina Dvorakova, Claire M Payne, Margaret E Tome, et al.
Journal of the National Cancer Institute
|
April 6, 1994
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial
F L Meyskens, E Surwit, T E Moon, et al.
Cancer Biology & Therapy
|
December 9, 2014
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
Betty K Samulitis, Kelvin W Pond, Erika Pond, et al.
Experimental and Therapeutic Medicine
|
April 25, 2012
Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance
Margaret E Tome, Jennifer B Frye, Donna L Coyle, et al.
Page
of 19